Business Wire—Organ Recovery Systems’ LifePort Liver Transporter Preserves First Livers for Transplant as Part of the PILOT Continued Access Study

LifePort Liver Transporter has not been cleared or approved by FDA, and the safety and effectiveness of the LifePort Liver Transporter has not been established. LifePort Liver Transporter is not available for sale within the United States.

We are proud to announce that the first livers have officially been transplanted using the LifePort®Liver Transporter as part of the PILOT™ Continued Access Study. The first livers preserved with the LLT under Continued Access were transplanted at University Hospital in Newark, NJ. Rutgers New Jersey Medical School is the first of a larger effort to further investigate the benefits of integrating LLT into existing transplant programs at participating medical centers.

 

“I am extremely excited to finally be able to use oxygenated HMP for my patients as a targeted intervention to improve logistics, outcomes, and access to transplant by safely facilitating the use of Extended Criteria and DCD livers,” said Dr. James V. Guarrera.

Business Wire is a trusted source for news organizations, journalists, investment professionals and regulatory authorities, delivering news directly into editorial systems and leading online news sources via its multi-patented NX network.

Tagged In:

The Latest

Check out the most recent posts

Zach, Clinical and Technical Advisor

Zach, Clinical and Technical Advisor

I joined ORS in the fall of 2025 as a Clinical and Technical Advisor, where I provide real-time client support and training on LifePort devices. Prior to my role here, I worked at Network for Hope as a Surgical Preservation Coordinator, assisting local transplant...

Optimizing Kidney Perfusion: The Role of End-Ischemic Pumping

Optimizing Kidney Perfusion: The Role of End-Ischemic Pumping

Webinar sponsored by Organ Recovery Systems through The Alliance - recording now available! Thursday, November 5 2:00 pm - 3:00 pm  EST Watch Recording Now! Featured Presenter Michael J. Goldstein MD FACS is Director of the Division of Organ Transplantation at...